Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.81 and traded as high as $0.9132. Medicure shares last traded at $0.85, with a volume of 10,000 shares changing hands.
Medicure Price Performance
The stock has a market cap of $8.87 million, a PE ratio of -1.81 and a beta of 0.99. The business has a fifty day simple moving average of $0.76 and a two-hundred day simple moving average of $0.81. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.03.
Medicure (OTCMKTS:MCUJF – Get Free Report) last released its earnings results on Thursday, May 21st. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.The company had revenue of $5.79 million during the quarter, compared to analysts’ expectations of $3.63 million.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Featured Articles
- Five stocks we like better than Medicure
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
